scholarly journals Bioconjugated Pluronic Triblock-Copolymer Micelle-Encapsulated Quantum Dots for Targeted Imaging of Cancer: In Vitro and In Vivo Studies

Theranostics ◽  
2012 ◽  
Vol 2 (7) ◽  
pp. 705-713 ◽  
Author(s):  
Liwei Liu ◽  
Ken-Tye Yong ◽  
Indrajit Roy ◽  
Wing-Cheung Law ◽  
Ling Ye ◽  
...  
2009 ◽  
Vol 1241 ◽  
Author(s):  
Anna Fucikova ◽  
Jan Valenta ◽  
Ivan Pelant ◽  
Vitezslav Brezina

AbstractThe commercially available semiconductor quantum dots have been proven to be slightly to significantly toxic by recent publications depending on the chemical composition. We are developing new non-toxic fluorescent labels based on (i) nanocrystalline silicon, suitable for in vivo studies due to their biodegrability, and on (ii) nanodiamonds, intended mainly for in vitro use due to their long-term stability and nondegradilibity.


Nano Letters ◽  
2010 ◽  
Vol 10 (8) ◽  
pp. 2843-2848 ◽  
Author(s):  
Jianfei Zhang ◽  
Jiechao Ge ◽  
Michael D. Shultz ◽  
Eunna Chung ◽  
Gurpreet Singh ◽  
...  

2020 ◽  
Vol Volume 15 ◽  
pp. 6519-6529 ◽  
Author(s):  
Xiumei Tian ◽  
Ao Zeng ◽  
Ziying Liu ◽  
Cunjing Zheng ◽  
Yuezi Wei ◽  
...  

2007 ◽  
Vol 22 (3) ◽  
pp. 405 ◽  
Author(s):  
Se-Lim Kim ◽  
Hwan-Jeong Jeong ◽  
Eun-Mi Kim ◽  
Chang-Moon Lee ◽  
Tae-Hyoung Kwon ◽  
...  

2001 ◽  
Vol 5 (8) ◽  
pp. 645-651
Author(s):  
M. Peeva ◽  
M. Shopova ◽  
U. Michelsen ◽  
D. Wöhrle ◽  
G. Petrov ◽  
...  
Keyword(s):  

2005 ◽  
Vol 25 (1_suppl) ◽  
pp. S198-S198
Author(s):  
Joseph R Meno ◽  
Thien-son K Nguyen ◽  
Elise M Jensen ◽  
G Alexander West ◽  
Leonid Groysman ◽  
...  

1994 ◽  
Vol 72 (06) ◽  
pp. 942-946 ◽  
Author(s):  
Raffaele Landolfi ◽  
Erica De Candia ◽  
Bianca Rocca ◽  
Giovanni Ciabattoni ◽  
Armando Antinori ◽  
...  

SummarySeveral “in vitro” and “in vivo” studies indicate that heparin administration may affect platelet function. In this study we investigated the effects of prophylactic heparin on thromboxane (Tx)A2 biosynthesis “in vivo”, as assessed by the urinary excretion of major enzymatic metabolites 11-dehydro-TxB2 and 2,3-dinor-TxB2. Twenty-four patients who were candidates for cholecystectomy because of uncomplicated lithiasis were randomly assigned to receive placebo, unfractionated heparin, low molecular weight heparin or unfractionaed heparin plus 100 mg aspirin. Measurements of daily excretion of Tx metabolites were performed before and during the treatment. In the groups assigned to placebo and to low molecular weight heparin there was no statistically significant modification of Tx metabolite excretion while patients receiving unfractionated heparin had a significant increase of both metabolites (11-dehydro-TxB2: 3844 ± 1388 vs 2092 ±777, p <0.05; 2,3-dinor-TxB2: 2737 ± 808 vs 1535 ± 771 pg/mg creatinine, p <0.05). In patients randomized to receive low-dose aspirin plus unfractionated heparin the excretion of the two metabolites was largely suppressed thus suggesting that platelets are the primary source of enhanced thromboxane biosynthesis associated with heparin administration. These data indicate that unfractionated heparin causes platelet activation “in vivo” and suggest that the use of low molecular weight heparin may avoid this complication.


2020 ◽  
Vol 72 (5) ◽  
Author(s):  
Mario Fadin ◽  
Maria C. Nicoletti ◽  
Marzia Pellizzato ◽  
Manuela Accardi ◽  
Maria G. Baietti ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document